30 results on '"Rizzo Manfredi"'
Search Results
2. Cilostazol for the treatment of distal symmetrical polyneuropathy in diabetes mellitus: Where do we stand?
3. The importance of arterial stiffness in pediatric patients with type 1 diabetes mellitus: What's new?
4. Emerging treatment strategies for polycystic ovary syndrome women with obesity: Focus on glucagon-like peptide-1 receptor agonists
5. Can tirzepatide untie the Gordian knot of eating disorders among individuals with type 2 diabetes and obesity?
6. The effect of SGLT2 inhibitors and GLP1 receptor agonists on arterial stiffness: A meta-analysis of randomized controlled trials
7. Managing cardio-renal-metabolic risk in patients with type 2 diabetes: the role of finerenone
8. Analysis of the therapeutic potential of miR-124 and miR-16 in non-alcoholic fatty liver disease
9. Understanding the mechanisms mediating cardio-renal benefit of empagliflozin in type 2 diabetes mellitus
10. Effect of semaglutide versus other glucagon-like peptide-1 receptor agonists on cardio-metabolic risk factors in patients with type 2 diabetes: A systematic review and meta-analysis of head-to-head, phase 3, randomized controlled trials
11. GLP-1 receptor agonists and SGLT2 inhibitors: The need to shed light on their safety risks real dimension and possible mechanisms
12. PUFA treatment in patients with gestational diabetes mellitus: Lights and shadows
13. The role of atherogenic lipoproteins in diabetes: Molecular aspects and clinical significance
14. ORal anticoaGulants in diAbetic and Nondiabetic patients with nOn-valvular atrial fibrillatioN (ORGANON)
15. The effect of SGLT2 inhibitors, GLP1 agonists, and their sequential combination on cardiometabolic parameters: A randomized, prospective, intervention study
16. Metformin in SARS-CoV-2 infection: A hidden path – from altered inflammation to reduced mortality. A review from the literature
17. Post-COVID syndrome, inflammation, and diabetes
18. Achievement of normoglycemia with tirzepatide in type 2 diabetes mellitus: A step closer to drug-induced diabetes remission?
19. GLP-1 and dual GIP/GLP-1 receptor agonists in overweight/obese patients for atherosclerotic cardiovascular disease prevention: Where are we now?
20. Is subclinical cardiovascular disease linked with periodontal disease in diabetic and non-diabetic subjects?
21. The legacy effect in early-stage diabetes: Don't stay by me, cardiovascular disease!
22. Sodium-glucose co-transporter-2 (SGLT-2) inhibitors and uric acid: More good news!
23. Epicardial, peripancreatic and other “orthotopic” excessive fat deposition in south Asians and Europeans: Are differences clinically relevant?
24. Upstream comprehensive management of individuals with diabetes with multimorbidity and frailty to act against amputation
25. Lipoprotein subclasses and early kidney dysfunction in young type 1 diabetes mellitus patients
26. Obesity and nonalcoholic fatty liver disease in type 1 diabetes mellitus patients
27. Weight response to GLP-1 receptor agonists: Why women do it better?
28. Precision diabetology: Where do we stand now?
29. Monitoring the liver as a part of the cardio-renal-metabolic continuum – What is cooking and burning with non-invasive tests and treatment options?
30. Weight response to GLP-1 receptor agonists: Why women do it better?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.